Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

NexMed and Novartis end anti-fungal drug development
1888 Press Release
Sunday, July 12, 2009 - 11:05am
tags:
NexMed, Novartis, anti-fungal
Dr. Reddy's to release Q1 FY10 results on Jul 21, 2009
1888 Press Release
Sunday, July 12, 2009 - 11:04am
tags:
Dr Reddy's
Loeb's Third Point - Buying Pharmacuetical & Biotech Stocks
Seeking Alpha
Sunday, July 12, 2009 - 11:00am
tags:
Daniel Loeb
Elder Pharmaceuticals Sets Up Elvista – A Division Dedicated to Tap Rural Markets
pr.com
Sunday, July 12, 2009 - 10:59am
tags:
Elder Pharmaceuticals
Martek Biosciences: Worth Revisiting
Seeking Alpha
Sunday, July 12, 2009 - 9:59am
tags:
Martek Biosciences
Blood Thinner's Approval A Muted Win For Lilly
Forbes
Saturday, July 11, 2009 - 8:52am
tags:
blood thinners, Effient, Eli Lilly, Daiichi Sankyo, black box, FDA
Vertex Pulls a Wimpy
Motley Fool
Saturday, July 11, 2009 - 8:51am
tags:
Vertex Pharmaceuticals
Pharmas, Hospitals Fall Due to Health Care Reform Troubles
Seeking Alpha
Saturday, July 11, 2009 - 8:43am
tags:
healthcare reform, Abbott Laboratories, JNJ, Eli Lilly, Merck, Pfizer
Merck Strong in Cardiovasculars
Yahoo/Zacks.com
Saturday, July 11, 2009 - 8:35am
tags:
Merck, Portola Pharmaceuticals, Schering Plough, Zetia, Vernakalant, Cardiome, Vytorin
Par Gets Tentative Approval For Once-Daily Tramadol Generic
WSJ Online
Friday, July 10, 2009 - 10:07am
tags:
Par Pharmaceutical, Tramadol, generics
Bristol exec hints of Onglyza launch strategy
Fierce Pharma
Friday, July 10, 2009 - 9:40am
tags:
Bristol-Myers Squibb, Onglyza, AstraZeneca
Endo Pharma In Licensing Deal For Bioniche's Bladder-Cancer Drug
WSJ Online
Friday, July 10, 2009 - 9:31am
tags:
Endo, bladder cancer, licensing, Bioniche Pharma, Urocidin
Why Healthcare Is a Good Defensive Sector
Seeking Alpha
Friday, July 10, 2009 - 9:28am
tags:
JNJ, Merck, Pfizer
Johnson & Johnson Completes Acquisition of Cougar Biotechnology
Yahoo
Friday, July 10, 2009 - 9:26am
tags:
JNJ, M&A, Cougar Biotechnology
Human Genome Sciences' anthrax drug works in tests
Yahoo/AP
Friday, July 10, 2009 - 8:53am
tags:
Human Genome Sciences, anthrax, ABthrax
What's a Biodollar Worth? Let's Ask Vertex
InVivo
Friday, July 10, 2009 - 8:51am
tags:
Vertex Pharmaceuticals, Telaprevir
[video]Mad About Options: Celgene Flashback
TheStreet.com
Friday, July 10, 2009 - 8:48am
tags:
options, Celgene
Swine Flu Update: Vaccine for Kids, Tamiflu Resistance
WSJ Online
Friday, July 10, 2009 - 8:19am
tags:
swine flu, vaccines, Tamiflu, H1N1
Pfizer plans to appeal Canada ruling on Norvasc
Yahoo/AP
Friday, July 10, 2009 - 8:17am
tags:
Pfizer, Canada, Norvasc, antihypertensives
Ranbaxy Expects FDA Response on Drug Ban ‘Very Soon’
Bloomberg
Friday, July 10, 2009 - 8:15am
tags:
Ranbaxy, FDA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.